Metraipolis › archive › dc_ff62923e2443
CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41972732
- DOI
- 10.3390/cells15070644
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T10:07:35.574Z
- SHA-256 of the archived text
f19ea512c19c1e59daaf9b174af0192a75430acb236b1c4b05c6f9fba6edcc5b- Stable URL of this page
https://metraipolis.com/documento/dc_ff62923e2443
How to cite
CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732 — Europe PMC (en), https://europepmc.org/article/MED/41972732 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff62923e2443 (Metraipolis archive dc_ff62923e2443, sha256 f19ea512c19c1e59daaf9b174af0192a75430acb236b1c4b05c6f9fba6edcc5b)
BibTeX
@misc{dcff62923e2443,
title = {CRISPR-Cas9 Therapeutics in Early Clinical Development: Delivery and Molecular Diagnostics — Europe PMC PMID:41972732},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41972732},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff62923e2443; sha256 f19ea512c19c1e59daaf9b174af0192a75430acb236b1c4b05c6f9fba6edcc5b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41972732. Agents can read the archived copy with the MCP tool read_document.